Tocilizumab-anoh is approved for multiple conditions, including rheumatoid arthritis and COVID ... in 162 mg/0.9 mL in a single-dose prefilled syringe or single-dose autoinjector.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Avtozma (tocilizumab-anoh, Celltrion) is approved for the treatment of multiple autoimmune diseases, including rheumatoid arthritis ... with a single-dose syringe or autoinjector.

SK hynix shares tumble after DeepSeek’s low-cost AI model shakes chip market ...

After hours: January 30 at 6:13:44 PM EST Loading Chart for PEN ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to ACTEMRA.

Rheumatoid arthritis (RA) is an inflammatory, autoimmune condition that affects not only joints but also organs, including eyes. While it can have painful and debilitating effects if left untreated, ...

Samsung has since clarified that Bluetooth support for the S Pen is, in fact, gone. According to Samsung, the blog post was made in error, and the Galaxy S25 Ultra will not offer any Bluetooth ...

The IV infusion is provided as 80 mg/4 mL (20 mg/mL), 200 mg/10 mL (20 mg/mL), 400 mg/20 mL (20 mg/mL) and the SC injection comes in 162 mg/0.9 mL in a single-dose prefilled syringe or single-dose ...

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for patients aged two or over who are hospitalised with severe COVOD-19 symptoms.